Showing results (251-260 of 756) with videos related to
Sort By:
Pageof 76
International Journal of Molecular Sciences|February 15, 2022
Imaging the Kidney with an Unconventional Scanning Electron Microscopy Technique: Analysis of the Subpodocyte Space in Diabetic MiceSara Conti, Giuseppe Remuzzi, Ariela Benigni, et al.Expert Opinion on Pharmacotherapy|September 8, 2005
Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockadeAneliya Parvanova, Carlos Chiurchiu, Piero Ruggenenti, et al.Nature Reviews. Nephrology|August 31, 2016
Podocyte-actin dynamics in health and diseaseLuca Perico, Sara Conti, Ariela Benigni, et al.Expert Opinion on Therapeutic Targets|June 1, 2019
A preclinical overview of emerging therapeutic targets for glomerular diseasesPaola Cassis, Carlamaria Zoja, Luca Perico, et al.Microorganisms|January 13, 2019
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic SyndromeSimona Buelli, Carlamaria Zoja, Giuseppe Remuzzi, et al.Pflugers Archiv : European Journal of Physiology|September 19, 2009
Angiotensin receptors as determinants of life spanPaola Cassis, Sara Conti, Giuseppe Remuzzi, et al.Expert Opinion on Emerging Drugs|November 8, 2014
Novel effective drugs for diabetic kidney disease? or not?Giorgio Gentile, Daniela Mastroluca, Piero Ruggenenti, et al.Scientific Reports|February 20, 2026
A scanning electron microscopy-based approach to explore subpodocyte space remodeling in diabetic kidneys of mice and humansSara Conti, Ariela Benigni, Giuseppe Remuzzi, et al.Journal of Nephrology|September 24, 2002
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiencyRoberto Pisoni, Rita Faraone, Piero Ruggenent, et al.Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.Pageof 76